Orthocell Limited (ASX:OCC) Announces Record Revenue and Market Expansion
Orthocell (ASX:OCC) reports record revenue and strategic market expansion in its latest quarterly update.
Category: Healthcare
HITIQ Limited (ASX: HIQ) Reports R&D Tax Incentive Receipt
HITIQ Limited (ASX: HIQ) announces $1.6 million R&D Tax Incentive receipt and related repayment updates.
First Graphene Limited (ASX:FGR) Responds to ASX Price Query
First Graphene Limited (ASX:FGR) addresses ASX concerns regarding price movements and highlights its ongoing commercial developments.
Immuron Limited (ASX:IMC) Announces Travelan® Clinical Trial Update
Immuron Limited announces positive Phase 2 results for Travelan®, with FDA submission pending and strong immunology findings.
Matrix Composites & Engineering Ltd (ASX:MCE) Secures Major Contract
Matrix Composites secures a $7M contract from Stena Drilling for Deepwater Drilling Riser Buoyancy Systems, strengthening its market position.
Mesoblast Limited (ASX:MSB) Completes A$260 Million Capital Raise
Mesoblast Limited raises A$260M to fund the launch of Ryoncil and expand clinical development.
EQ Resources Ltd (ASX:EQR) Announces Leadership Transition
EQ Resources Ltd announces Kevin MacNeill’s transition to CTO as part of a growth strategy, focusing on operational improvements.
Tivan Limited (ASX: TVN) Reports Ultra High-Grade Fluorite Assays at Sandover
Tivan Limited (ASX: TVN) reveals ultra high-grade fluorite assays from the Sandover Project, indicating promising exploration and development potential.
Atomo Diagnostics Limited (ASX:AT1) Signs Long-Term Agreement for HIV Self-Testing
Atomo Diagnostics Limited (ASX:AT1) enters a five-year supply agreement with Newfoundland Diagnostics for its HIV self-testing products.
Bioxyne Limited (ASX:BXN) Announces Revenue Growth Plans
Bioxyne Limited (ASX:BXN) reports strong revenue growth projections and a manufacturing facility expansion in its latest investor update.